Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2014-000457-36-FR
EUCTR2014-000457-36-FR
Active, not recruiting
Phase 1

A comparative dynamic study of myocardial perfusion reserve explored by cardiac WATER labelled O-15 -PET vs Tc99mibi D-SPECT in coronAry arterY disease. Protocol WATER -DAY - WATER-DAY

CHU CAE0 sitesJanuary 15, 2015
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsPatient suspect d’une maladie coronaire et/ou syndrome coronarien ST-MedDRA version: 17.1Level: LLTClassification code 10011099Term: Coronary diseaseSystem Organ Class: 100000004849Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Patient suspect d’une maladie coronaire et/ou syndrome coronarien ST-
Sponsor
CHU CAE
Status
Active, not recruiting
Last Updated
9 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 15, 2015
End Date
TBD
Last Updated
9 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
CHU CAE

Eligibility Criteria

Inclusion Criteria

  • •\- patient entre 18 et 70 ans
  • •\- patient suspect d’une maladie coronaire et/ou syndrome coronarien ST\-
  • •\- Patient ayant été informé de l’étude et ayant donné son consentement éclairé écrit et signé
  • •\- Patient affilié à un régime de sécurité sociale.
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) yes
  • •F.1\.2\.1 Number of subjects for this age range 20
  • •F.1\.3 Elderly (\>\=65 years) yes
  • •F.1\.3\.1 Number of subjects for this age range 20

Exclusion Criteria

  • •\-Patient présentant une histoire récente d’infarctus du myocarde et de STEMI, angor instable)
  • •\-Patient ayant une pathologie extra\-cardiaque dont le pronostic peut interférer avec la décision de traitement
  • •\-Femme enceinte ou allaitante
  • •\- Patient allergique aux produits de contraste lors de la coronarographie
  • •\- Patient ayant une clairance MDRD \< 60 ml/min
  • •\-Patient sous tutelle ou curatelle, ou incapable de comprendre le but de l’étude

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 2
Comparison in myocardial perfusion between the intracoronary versus intralesional eptifibatide administration in acute myocardial infarctiocardiovascular disease.Certain current complications following acute myocardial infarctionI20-I25
IRCT2016122722134N4Vice Chancellor for research of Isfahan University of Medical Sciences60
Completed
Not Applicable
Myocardial perfusion with an intravascular contrast agentCoronary artery diseaseCirculatory SystemChronic ischaemic heart disease
ISRCTN53688797King's College London (UK)156
Active, not recruiting
Not Applicable
Quantitative Assessment of Myocardial Perfusion with Magnetic Resonance Using an Intravascular Contrast AgentIschemic cardiomyopathy, with inducible ischemia and clinical indication to cardiac revascularizationMedDRA version: 9.1Level: LLTClassification code 10055217Term: Ischemic cardiomyopathy
EUCTR2008-004895-39-GBKing's College London
Not yet recruiting
Not Applicable
Investigation of the relation between myocardial remodeling and glucose metabolism in patients with post myocarditis
JPRN-UMIN000053339Fukushima Medical University30
Completed
Not Applicable
Assessment of Myocardial Perfusion Linked to Infarction and Fibrosis Explored with DSCT.
JPRN-UMIN000016353Department of Radiology,Mie University Graduate School of Medicine200